We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$2.21B
AUM Growth
+$77.2M
Cap. Flow
-$76.2M
Cap. Flow %
-3.46%
Top 10 Hldgs %
61.53%
Holding
424
New
30
Increased
163
Reduced
133
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 2.77%
2 Healthcare 1.99%
3 Financials 1.98%
4 Industrials 1.67%
5 Energy 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAT icon
276
Waters Corp
WAT
$37B
$354K 0.02%
1,517
-222
-13% -$49K
CTSH icon
277
Cognizant
CTSH
$24.9B
$353K 0.02%
5,689
+124
+2% +$7.66K
MTD icon
278
Mettler-Toledo International
MTD
$28.6B
$352K 0.02%
444
+6
+1% +$4.33K
NGG icon
279
National Grid
NGG
$80.4B
$348K 0.02%
6,293
+680
+12% +$34.9K
FTV icon
280
Fortive
FTV
$17.9B
$347K 0.02%
7,209
+122
+2% +$5.51K
CMA
281
DELISTED
Comerica
CMA
$344K 0.02%
4,794
+52
+1% +$3.57K
ASML icon
282
ASML
ASML
$626B
$343K 0.02%
1,159
+4
+0.3% +$1.08K
CME icon
283
CME Group
CME
$96.3B
$343K 0.02%
1,708
+86
+5% +$17.6K
RSG icon
284
Republic Services
RSG
$64.8B
$343K 0.02%
3,829
-73
-2% -$6.39K
ARNA
285
DELISTED
Arena Pharmaceuticals Inc
ARNA
$341K 0.02%
7,500
KMX icon
286
CarMax
KMX
$8.13B
$338K 0.02%
3,861
+43
+1% +$4.04K
WELL icon
287
Welltower
WELL
$169B
$335K 0.02%
4,102
VTR icon
288
Ventas
VTR
$48B
$325K 0.01%
5,626
-225
-4% -$14.1K
AZN icon
289
AstraZeneca
AZN
$263B
$324K 0.01%
3,253
+408
+14% +$38.4K
EEMV icon
290
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
$320K 0.01%
5,451
+1,411
+35% +$81.9K
ATR icon
291
AptarGroup
ATR
$8.55B
$317K 0.01%
2,741
XEL icon
292
Xcel Energy
XEL
$48.8B
$317K 0.01%
4,986
+92
+2% +$5.76K
EXEL icon
293
Exelixis
EXEL
$13.3B
$316K 0.01%
+17,926
New +$304K
HBAN icon
294
Huntington Bancshares
HBAN
$34.4B
$311K 0.01%
20,642
-3,847
-16% -$56.4K
AON icon
295
Aon
AON
$76.5B
$309K 0.01%
1,482
VRTX icon
296
Vertex Pharmaceuticals
VRTX
$121B
$309K 0.01%
1,411
+58
+4% +$11.7K
ROK icon
297
Rockwell Automation
ROK
$53.4B
$306K 0.01%
1,508
-237
-14% -$43.9K
HSBC icon
298
HSBC
HSBC
$365B
$305K 0.01%
7,801
+2,328
+43% +$88.3K
SNY icon
299
Sanofi
SNY
$103B
$305K 0.01%
6,085
+744
+14% +$34.9K
OEF icon
300
iShares S&P 100 ETF
OEF
$20.1B
$304K 0.01%
2,108
-160
-7% -$22K

Similar funds

Ballentine Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Ballentine Partners held 424 positions worth $2.21B, up 3.6% from $2.13B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Ballentine Partners withdrew a net $76.2M in Q4 2019, closing 16 positions and reducing 133 holdings. Its most notable exit was iShares 0-1 Year Treasury Bond ETF, an estimated $3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.8% of assets, up from 2.5% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ballentine Partners opened a new position in iShares Russell 2000 Growth ETF worth $609K.

  • Ballentine Partners's largest Q4 2019 buy was iShares Russell 2000 Growth ETF: 2,843 shares worth $609K.
  • Ballentine Partners added most to Biogen in Q4 2019, an estimated $1.36M increase.
  • Ballentine Partners's biggest Q4 2019 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $23.1M.
  • Ballentine Partners fully exited iShares 0-1 Year Treasury Bond ETF in Q4 2019, selling an estimated $3M.
  • Ballentine Partners's ten largest holdings make up 62% of its $2.21B portfolio in Q4 2019.
  • Ballentine Partners opened 30 new positions and closed 16 in Q4 2019.
  • Ballentine Partners's portfolio value rose 3.6% quarter-over-quarter to $2.21B.

Based on Ballentine Partners's 13F filing for Q4 2019, filed 22 Jan 2020.